Name Charles Heidelberger Died January 18, 1983 | Education Harvard University | |
 | ||
Charles Heidelberger (December 23, 1920 – January 18, 1983) was a cancer researcher who developed and patented an anticancer drug called 5-Fluorouracil that remains widely used against cancers of the stomach, colon and breast. He was also director of basic research at the University of Southern California's Comprehensive Cancer Center. He received an American Cancer Society National Award in 1974. Heidelberger served on editorial boards of various scientific journals: Cancer Research, Molecular Pharmacology, Biochemical Pharmacology, the International Journal of Cancer, In Vitro, and the Journal of Medicinal Chemistry. He served as director for Basic Research of the USC Cancer Center, and was a Distinguished Professor at the University of Southern California.
Contents
Notable awards and distinctions
Heidelberger received the following awards:
Notable publications
Most notable publications:
Career
Heidelberger was born in New York City on December 23, 1920. His father Michael was a famous immunologist. Heidelberger graduated from Harvard with S.B in chemistry in 1942, and with M.S. and Ph.D. degrees in organic chemistry in 1944 and 1946 respectively, also from Harvard. He became a Professor of Oncology at the University of Wisconsin in 1948. In 1960 he received American Cancer Society Professorship of Oncology which he retained until 1976. In 1976 Heidelberger accepted position of Professor of Biochemistry and Pathology, as well as Director for Basic Research of the USC Cancer Center. He became a Distinguished Professor at the University of Southern California in 1981. He died of cancer, the disease he devoted his life to eradicating.